selenium has been researched along with Hematologic Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwala, S; Bakhshi, S; Bansal, PG; Dhawan, D; Dwivedi, S; Ganguly, S; Gonmei, Z; Srivastava, R; Toteja, GS | 1 |
| Claxton, D; Desai, D; Dovat, S; Ehudin, MA; Golla, U; Potlakayala, SD; Rudrabhatla, SV; Sharma, A; Trivedi, D | 1 |
| Evans, SO; Jameson, MB | 1 |
| Adamietz, IA; Buentzel, J; Huebner, J; Micke, O; Muecke, R; Schomburg, L | 1 |
| Fitzgibbon, J; Joel, S; Kassam, S; Lister, A; Montoto, S; Rohatiner, A; Sieniawska, C; Stevens, J; Waters, R | 1 |
1 review(s) available for selenium and Hematologic Neoplasms
| Article | Year |
|---|---|
Therapeutic Benefits of Selenium in Hematological Malignancies.
Topics: Hematologic Neoplasms; Humans; Neoplasms; Quality of Life; Selenium | 2022 |
4 other study(ies) available for selenium and Hematologic Neoplasms
| Article | Year |
|---|---|
Prevalence of micronutrient deficiency and its impact on the outcome of childhood cancer: A prospective cohort study.
Topics: Child; Copper; Folic Acid; Hematologic Neoplasms; Humans; Longitudinal Studies; Malnutrition; Micronutrients; Neoplasms; Prevalence; Prospective Studies; Selenium; Vitamin B 12; Vitamins; Zinc | 2022 |
Adding selenium to chemotherapy and radiation in haematological malignancies: clinical trials are justified.
Topics: Female; Hematologic Neoplasms; Humans; Male; Selenium | 2014 |
Serum selenium deficiency in patients with hematological malignancies: is a supplementation study mandatory?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dietary Supplements; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Selenium; Spectrophotometry, Atomic | 2014 |
Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Follow-Up Studies; Hematologic Neoplasms; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Male; Middle Aged; Prognosis; Selenium; Serum Albumin; Treatment Outcome; Young Adult | 2011 |